Adrenomedullin: a novel hypotensive peptide isolated from human pheochromocytoma.
about
Visualization of the calcitonin receptor-like receptor and its receptor activity-modifying proteins during internalization and recyclingStructural basis for extracellular interactions between calcitonin receptor-like receptor and receptor activity-modifying protein 2 for adrenomedullin-specific bindingThe GPCR modulator protein RAMP2 is essential for angiogenesis and vascular integrityDiscovery of adrenomedullin in rat ischemic cortex and evidence for its role in exacerbating focal brain ischemic damageCalcitonin and calcitonin receptors: bone and beyondGene expression profiling in the human hypothalamus-pituitary-adrenal axis and full-length cDNA cloningCirculating Biomarkers of Diabetic Retinopathy: An Overview Based on PhysiopathologyVascular endothelial dysfunction and pharmacological treatmentOxygen sensing in retinal health and diseaseEmerging role of TRP channels in cell migration: from tumor vascularization to metastasisThe ADMR receptor mediates the effects of adrenomedullin on pancreatic cancer cells and on cells of the tumor microenvironmentNew role of biomarkers: mid-regional pro-adrenomedullin, the biomarker of organ failureThe RAMP2/CRLR complex is a functional adrenomedullin receptor in human endothelial and vascular smooth muscle cellsIntermedin is a calcitonin/calcitonin gene-related peptide family peptide acting through the calcitonin receptor-like receptor/receptor activity-modifying protein receptor complexesIdentification of the human receptor activity-modifying protein 1 domains responsible for agonist binding specificityIdentification of novel adrenomedullin in mammals: a potent cardiovascular and renal regulatorFunctions of the cytoplasmic tails of the human receptor activity-modifying protein components of calcitonin gene-related peptide and adrenomedullin receptorsAdrenomedullin (ADM) in the human forearm vascular bed: effect of neutral endopeptidase inhibition and comparison with proadrenomedullin NH2-terminal 20 peptide (PAMP)CGRP receptors mediating CGRP-, adrenomedullin- and amylin-induced relaxation in porcine coronary arteries. Characterization with 'Compound 1' (WO98/11128), a non-peptide antagonistTissue hypoxygenation activates the adrenomedullin system in vivoAdrenomedullin in ovarian cancer: foe in vitro and friend in vivo?Reduced maternal expression of adrenomedullin disrupts fertility, placentation, and fetal growth in miceAdrenomedullin is expressed during rodent dental tissue development and promotes cell growth and mineralizationmRNA expression of novel CGRP1 receptors and their activity-modifying proteins in hypoxic rat lungThe effect of adrenomedullin on the L-type calcium current in myocytes from septic shock rats: signaling pathwayHydrops fetalis, cardiovascular defects, and embryonic lethality in mice lacking the calcitonin receptor-like receptor geneAdrenomedullin is a cross-talk molecule that regulates tumor and mast cell function during human carcinogenesis.A comparative study of the ability of calcitonin gene-related peptide and adrenomedullin(13 - 52) to modulate microvascular but not thermal hyperalgesia responses.Induction of adrenomedullin during hypoxia in cultured human glioblastoma cells.Influence of bed rest on plasma galanin and adrenomedullin at presyncope.Similar effects on rat renal mesangial cells by expressing different fragments of adrenomedullin gene in vitro.Significant changes of peripheral perfusion and plasma adrenomedullin levels in N-acetylcysteine long term treatment of patients with sclerodermic Raynauds phenomenon.Regulation of the histone demethylase JMJD1A by hypoxia-inducible factor 1 alpha enhances hypoxic gene expression and tumor growth.Epicardial-derived adrenomedullin drives cardiac hyperplasia during embryogenesis.Human adrenomedullin and its binding protein attenuate organ injury and reduce mortality after hepatic ischemia-reperfusion.Activation of calcitonin receptor and calcitonin receptor-like receptor by membrane-anchored ligands.Adrenomedullin up-regulates osteopontin and attenuates vascular calcification via the cAMP/PKA signaling pathway.Biomarkers in acute myocardial infarction.Chemical modification of class II G protein-coupled receptor ligands: frontiers in the development of peptide analogs as neuroendocrine pharmacological therapiesBiological and clinical roles of adrenomedullin in circulation control and cardiovascular diseases.
P2860
Q22254563-E24232F0-1E35-4D11-AD24-3AC991E9C9C3Q24298039-3B320B52-5398-427C-B10D-18F93FE0925EQ24304367-76A42F02-3F2B-4273-9F28-FB120E9BE20DQ24310856-631F1262-7C3B-4469-BE14-9A514BF49E90Q24643368-2561D4A4-4363-4788-BC4A-1337F7FE84D5Q24671792-B687722B-3F77-46B7-8BED-2748AEA380E1Q26744760-DE54C93D-B0DB-4ABE-B7CE-E2B5D4BF4B3AQ26774561-4148B4FC-187B-4887-A1FE-672A5C023D8FQ26827518-7D9C4564-951E-4C45-8E14-3863BFF97E47Q26829651-FDA94C70-EA2E-4FBD-AFAD-E38F28413957Q27339492-2F9EA33B-A448-4221-BB1F-E45976DC2F73Q28076596-B0BD665B-7954-4978-AFCE-45428B930DF9Q28142390-65D21A6C-1FE1-408B-9623-A2C2CE26D14BQ28184238-2B98D559-43BA-402C-91AE-ADF9FF5B389FQ28189792-0FC6D09F-8EF1-4D18-A4FD-B9A19D949835Q28237193-D2A4D32C-7D36-46C7-A8D5-13D94FC32FEFQ28291519-31DA8376-4984-458B-A827-B825DB03CC06Q28345545-1ABDE8BA-EDEF-40D5-A865-3CF28A54E0C1Q28345802-4D46750B-F072-43BA-86AE-A273112D9503Q28369890-5C624E15-50B1-46D4-9C2D-2A927C008555Q28481667-D8C9AB37-30E5-43D6-89B9-ED9EF1D3D9AEQ28510935-7B1E8648-B6F5-495D-A2CA-2267FDBDFEE5Q28564597-2C21C2DC-FAFD-4628-BEB1-826624291390Q28564935-C6028141-10D1-4EE7-907A-92FED1D8D80FQ28569073-FA5A1FC6-CA49-44A4-A4D1-F327C0ACE7C2Q28592688-BDA5B185-9C75-4C80-AA52-D5630A326610Q30445142-718E72FA-F94E-413D-9B58-C04189A798E7Q30896011-5F05FE86-5789-4754-8DAD-32222088B6D2Q31461184-64DA6972-ACDB-474C-916A-70BD22DF6C35Q33165656-B925ED17-6397-4184-A63D-BE6A0992C16BQ33217270-5D67B22B-3B2A-43A1-9C78-760C64938BC4Q33230678-C16718A6-0077-4FA8-A5F7-C5AAF620A427Q33558169-7C86CA80-5226-4ED4-B9F5-8944DFD3A05AQ33564987-0454BDE2-25DF-4243-B920-BDE968EF572AQ33565348-9156A0D5-658E-45BE-9F28-518025646BE3Q33569613-A18EDA08-C54A-42DB-B2F8-7252B7E3D0BAQ33577625-FA43C417-ED89-4A57-BADA-BD7EF92B7142Q33596823-7B1CA386-4F99-4CD2-94C6-7D651704BF5EQ33624771-B624E970-203A-45CB-BC33-7586B7C94FDEQ33673678-72CCCD33-F016-43D2-9DBF-624ACE8356E1
P2860
Adrenomedullin: a novel hypotensive peptide isolated from human pheochromocytoma.
description
1993 nî lūn-bûn
@nan
1993年の論文
@ja
1993年学术文章
@wuu
1993年学术文章
@zh
1993年学术文章
@zh-cn
1993年学术文章
@zh-hans
1993年学术文章
@zh-my
1993年学术文章
@zh-sg
1993年學術文章
@yue
1993年學術文章
@zh-hant
name
Adrenomedullin: a novel hypotensive peptide isolated from human pheochromocytoma.
@en
Adrenomedullin: a novel hypotensive peptide isolated from human pheochromocytoma.
@nl
type
label
Adrenomedullin: a novel hypotensive peptide isolated from human pheochromocytoma.
@en
Adrenomedullin: a novel hypotensive peptide isolated from human pheochromocytoma.
@nl
prefLabel
Adrenomedullin: a novel hypotensive peptide isolated from human pheochromocytoma.
@en
Adrenomedullin: a novel hypotensive peptide isolated from human pheochromocytoma.
@nl
P2093
P356
P1476
Adrenomedullin: a novel hypotensive peptide isolated from human pheochromocytoma.
@en
P2093
Kawamoto M
Kitamura K
Nakamura S
P304
P356
10.1006/BBRC.1993.1451
P407
P577
1993-04-01T00:00:00Z